89 related articles for article (PubMed ID: 9188882)
1. Abnormal corneometric values of non-lesional plaque-type psoriatic skin.
Mussi A; Carducci M; Bonifati C; Fazio M; Ameglio F
Acta Derm Venereol; 1997 May; 77(3):237-8. PubMed ID: 9188882
[No Abstract] [Full Text] [Related]
2. Effect of data normalization for age on the correlations between corneometric values and serum molecule levels in plaque-type psoriatic patients.
Carducci M; Mussi A; Bonifati C; Pietravalle M; Alemanno L; Fazio M; Ameglio F
Acta Derm Venereol; 1997 Mar; 77(2):110-4. PubMed ID: 9111819
[TBL] [Abstract][Full Text] [Related]
3. Correlation of lesional skin corneometry values with serum E-selectin levels and disease severity in patients affected by plaque-type psoriasis: recovery after effective therapy.
Carducci M; Mussi A; Bonifati C; Tomaselli R; Onorati MT; Trento E; Ameglio F
J Dermatol; 1995 Jul; 22(7):475-9. PubMed ID: 7560436
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent fibre-optic confocal imaging of lesional and non-lesional psoriatic skin compared with normal skin in vivo.
Suihko C; Serup J
Skin Res Technol; 2012 Nov; 18(4):397-404. PubMed ID: 22111991
[TBL] [Abstract][Full Text] [Related]
5. Increased interstitial histamine concentration in the psoriatic plaque.
Krogstad AL; Lönnroth P; Larson G; Wallin BG
J Invest Dermatol; 1997 Nov; 109(5):632-5. PubMed ID: 9347790
[TBL] [Abstract][Full Text] [Related]
6. The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris.
Alessandrini F; Stachowitz S; Ring J; Behrendt H
J Invest Dermatol; 2001 Mar; 116(3):394-400. PubMed ID: 11231313
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of human papilloma virus type 5 DNA in lesional and non-lesional skin scales of Italian plaque-type psoriatic patients: association with disease severity.
Prignano G; Ferraro C; Mussi A; Stivali F; Trento E; Bordignon V; Crescimbeni E; Salvati G; Degener AM; Ameglio F
Clin Microbiol Infect; 2005 Jan; 11(1):47-51. PubMed ID: 15649303
[TBL] [Abstract][Full Text] [Related]
8. Application of Photoacoustic Methods and Confocal Microscopy for Monitoring of Therapeutic Response in Plaque Psoriasis.
Ossadnik K; Philipp S; Bost W; Fournelle M; Richter H; Lademann J
Skin Pharmacol Physiol; 2018; 31(6):308-315. PubMed ID: 30184523
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive skin biomarkers quantification of psoriasis and atopic dermatitis: cytokines, antioxidants and psoriatic skin auto-fluorescence.
Portugal-Cohen M; Horev L; Ruffer C; Schlippe G; Voss W; Ma'or Z; Oron M; Soroka Y; Frušić-Zlotkin M; Milner Y; Kohen R
Biomed Pharmacother; 2012 Jun; 66(4):293-9. PubMed ID: 22397760
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cutaneous surface parameters in psoriatic patients.
Cannavò SP; Guarneri F; Giuffrida R; Aragona E; Guarneri C
Skin Res Technol; 2017 Feb; 23(1):41-47. PubMed ID: 27270565
[TBL] [Abstract][Full Text] [Related]
11. Skin thickness in psoriasis.
Rogers S
Clin Exp Dermatol; 1992 Sep; 17(5):324-7. PubMed ID: 1458636
[TBL] [Abstract][Full Text] [Related]
12. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis.
Bhawan J; Bansal C; Whren K; Schwertschlag U;
J Cutan Pathol; 2004 Aug; 31(7):471-6. PubMed ID: 15239676
[TBL] [Abstract][Full Text] [Related]
13. Stimulated mitotic counts in the non-lesional skin of patients with psoriasis and controls.
Rico MJ; Halprin KM; Baker L; Cayer M; Taylor JR
Br J Dermatol; 1985 Aug; 113(2):185-8. PubMed ID: 4027186
[TBL] [Abstract][Full Text] [Related]
14. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
Johansen C; Flindt E; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2005 Jun; 124(6):1284-92. PubMed ID: 15955105
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
[TBL] [Abstract][Full Text] [Related]
16. Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions.
Chen SC; de Groot M; Kinsley D; Laverty M; McClanahan T; Arreaza M; Gustafson EL; Teunissen MB; de Rie MA; Fine JS; Kraan M
Arch Dermatol Res; 2010 Mar; 302(2):113-23. PubMed ID: 19517126
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1: a key inflammatory mediator in psoriasis?
Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN.
Keermann M; Kõks S; Reimann E; Prans E; Abram K; Kingo K
BMC Genomics; 2015 Apr; 16(1):322. PubMed ID: 25897967
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotyping of dendritic cells in lesional, perilesional and distant skin of chronic plaque psoriasis.
Alshenawy HA; Hasby EA
Cell Immunol; 2011; 269(2):115-9. PubMed ID: 21470599
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation.
Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Giuliano A; Sabato S; Stramazzotti D; Gulini E; Dusi D; De Blasio S; Fabris G; Offidani A
Int J Immunopathol Pharmacol; 2009; 22(2):371-7. PubMed ID: 19505391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
